Ritlecitinib
Drug · tier A · 4 trials (1 recruiting) · 8 publications · score 62.5
Tacrolimus
Drug · tier B · 8 trials (1 recruiting) · 11 publications · score 56.5
Ritlecitinib
Drug · tier B · 4 trials (1 recruiting) · 8 publications · score 52.5
Upadacitinib
Drug · tier B · 3 trials (1 recruiting) · 6 publications · score 45.5
Methotrexate
Drug · tier B · 8 trials (0 recruiting) · 2 publications · score 42.5
Afamelanotide
Biologic · tier B · 5 trials (0 recruiting) · 3 publications · score 36.0
Povorcitinib
Drug · tier B · 3 trials (0 recruiting) · 2 publications · score 30.5
Research map, not treatment advice. Built 2026-10-07.